Judging by photos of startup events packed with 30-something entrepreneurs—often women—you might think so. But think again! A recent French study by BPI shows that starting your first business after 50 can actually help you handle stress better. Plus, women are...
Image by pikisuperstar on Freepik On 18th October, Mablink Bioscience (“Mablink”) –Lyon, France– announced an agreement to be acquired by Eli Lilly and Company (“Lilly”). Mablink was created in December 2018, raised a total of EUR31m in equity and was readily...
The pending acquisition reflects the potential of Mablink’s existing pipeline and proprietary PSARLink™ technology for development of additional drug conjugates. October 18, 2023 – Lyon, France Mablink Bioscience (“Mablink”), a pre-clinical biotechnology company...
June 15, 2023 – Lyon, France Mablink Bioscience (“Mablink”), a biotechnology company dedicated to advancing cancer therapy with next-generation antibody-drug conjugates (ADCs),today announced the appointment of Dr. Pejvack Motlagh, M.D., as Chief Medical...
January 20, 2023 – Lyon, France Mablink Bioscience (“Mablink”) announces the publication of a review article titled “Payload diversification: a key step in the development of antibody–drug conjugates”. Its authors Louise Conilh, Lenka Kyrych Sadilkova, Warren...
